Intervention not reported
Mean FEV1 % predicted ‐ azithromycin prophylaxis only · children with cystic fibrosis aged 12 years and under
1 finding from 1 review
Intervention not reported
Mean FEV1 % predicted ‐ ciprofloxacin prophylaxis only · children with cystic fibrosis aged 12 years and under
1 finding from 1 review
Intervention not reported
Episodes of pulmonary exacerbations ‐ azithromycin prophylaxis only · children with cystic fibrosis aged 12 years and under
The intervention leads to lower episodes of pulmonary exacerbations ‐ azithromycin prophylaxis only (high certainty).
1 finding from 1 review
Intervention not reported
Incidence of Pneumocystis carinii pneumonia infection in children with cancer ‐ trimethoprim‐sulfamethoxazole prophylaxis only · children with cancers aged 12 years and under
The intervention probably leads to lower incidence of Pneumocystis carinii pneumonia infection in children… (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality in children with HIV infection ‐ overall · children with HIV infection aged 12 years and under
The intervention showed no clear difference in mortality in children with HIV infection ‐ overall (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality in children with HIV infection ‐ co‐trimoxazole prophylaxis only · children with HIV infection aged 12 years and under
The intervention probably leads to lower mortality in children with HIV infection ‐ co‐trimoxazole… (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality in children with HIV infection ‐ isoniazid prophylaxis only · children with HIV infection aged 12 years and under
The intervention showed no clear difference in mortality in children with HIV infection ‐ isoniazid prophylaxis only (low certainty).
1 finding from 1 review
Intervention not reported
Incidence of adverse events ‐ overall · children with HIV infection aged 12 years and under
The intervention showed no clear difference in incidence of adverse events ‐ overall (moderate certainty).
1 finding from 1 review
Intervention not reported
Incidence of adverse events ‐ co‐trimoxazole prophylaxis only · children with HIV infection aged 12 years and under
The intervention showed no clear difference in incidence of adverse events ‐ co‐trimoxazole prophylaxis only (moderate certainty).
1 finding from 1 review
Intervention not reported
Incidence of adverse events ‐ isoniazid prophylaxis only · children with HIV infection aged 12 years and under
The intervention showed no clear difference in incidence of adverse events ‐ isoniazid prophylaxis only (moderate certainty).
1 finding from 1 review
Intervention not reported
Incidence of Pseudomonas infection in children with cystic fibrosis ‐ ciprofloxacin prophylaxis only · children with cystic fibrosis aged 12 years and under
The intervention showed no clear difference in incidence of Pseudomonas infection in children with cystic fibrosis… (moderate certainty).
1 finding from 1 review
Intervention not reported
Mean FEV1 % predicted · children with cystic fibrosis aged 12 years and under
1 finding from 1 review
Intervention not reported
Number of people who had not improved or had not been cured ( · children and adults with acute pneumonia
The intervention showed no clear difference in number of people who had not improved or had not been cured ( (low certainty).
1 finding from 1 review
Intervention not reported
Cough score Scale from: 0 (absent) to 3 (very severe) ( · children and adults with acute pneumonia
1 finding from 1 review
Intervention not reported
Adverse events ( · children and adults with acute pneumonia
1 finding from 1 review
Intervention not reported
Complications (e.g. medication change) · children and adults with acute pneumonia
1 finding from 1 review
Intervention not reported
Treatment failure at 1 month or less · patients with acute otitis media
The intervention led to higher treatment failure at 1 month or less; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 8 to 19 days · patients with acute otitis media
The intervention led to higher treatment failure at 8 to 19 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 20 to 30 days · patients with acute otitis media
The intervention showed no clear difference in treatment failure at 20 to 30 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 8 to 19 days · patients with acute otitis media
The intervention led to higher treatment failure at 8 to 19 days; GRADE not reported.
1 finding from 1 review